George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
lol !
https://www.facebook.com/fruitflowplus/posts/2426630544304603?__cft__[0]=AZU39RyRflTCP85NonOPbJDO-JCHUvLj_s7BEb7ewybdmhXUhTq0HQuAIn7FWkONBkyQSW6zkJ1v1r-SbckLYqjMNsh37uT3E5MvkLlgw1XPVAf9I7iaTjDdYi2r783FmAxkwAdmYC0pgvVNiUAHecbEBpZ6UCrgaHorZBbMRoWuG9v4UOndxllvne0HPnqfsfrP--UY2ORSeByN6sAwl6RuX49Q0GDogXXgkDT77w5r-g&__tn__=%2CO%2CP-R
With EFSA health claim regulations I think they will need to be careful what they can and cant say with regards to Fruitflow and Covid in Europe and i assume the same will apply in other countries that are regulated.
Hopefully the DSM big guns are working on this.
No FB post saying FF can help you “prepare for Covid”...., another secret being kept
W$
"Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow” (94). A 3 g dose (containing 65 mg of antiplatelet components) of Fruitflow® recently demonstrated antiplatelet effects that were approximately one-third the effect of 75 mg of aspirin in a double-blinded randomized clinical trial of 47 healthy subjects (95). Nutraceuticals such as these may serve as a safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding (19)."
NL, probably and it won't make any difference to cashflow.
Showing it here is just straw-clutching by some to make themselves feel better about the dire situation. Copy & paste doesn't work with PXS.
Big dilution coming up. Don't get spiked folks. It will be years before B/E.
It's as if the board can finally be arsed to provide news only because the AGM is coming up.
On the provexis site now great find Gixer . https://www.provexis.com/news/
Here is what Niamh O'Kennedy said about Fruitflow when asked will Fruitflow help to fight Covid-19 during the recent SmoFlo webinar
https://soundcloud.com/gix-er/covid-and-fruitflow/s-JyZwzfWUnRf
"Generally, only a limited number of food-derived compounds have been investigated for their antiplatelet effects clinically as of yet, whereby fish oils are synonymous. However, there has been some success in developing antiplatelet nutraceuticals. One such product is a water-soluble tomato-based nutraceutical given the trademarked name Fruitflow®. Fruitflow is now recognized as a functional product by the European Food Safety Authority (EFSA) with a recognized health claim that states that Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow"
Someone obviously has a bee in his bonnet about a certain poster, if it grinds you that much use the filter button, these derogatory childish comments put you in a bad light.
'course you do dear, 'course you do.
Sad
An excellent scholarly article which confirms what we all know, in that taking a product containing Fruitflow is very probably going to help someone fight off the effects of Covid-19 and have other beneficial effects as well.
But, no one doubts the excellence of fruitflow and this has been known for years but refuses to gain traction. The problem we have, IMO, is that DSM and Provexis have not made sufficient sale inroads to make enough money to turn a profit. Eleven years of spoof and groundless promises and we only have a third of a million quid gross income. How can that be justified or excused? Perhaps DSM are simply no good at marketing this product and the BOD are not proactive enough? I don't know, but something isn't right.
We are totally reliant on events in China IMO.
Gixer, by all means continue to discover excellent news about FF but to date, your research shows that the message is not getting through and I do wonder if it's too late.
Gixer... 'Do you think he reads the BB?'...no I don't think so...he was sent the information by a friendly source...but that source stopped sending right about the time the news dried up...
"Generally, only a limited number of food-derived compounds have been investigated for their antiplatelet effects clinically as of yet, whereby fish oils are synonymous. However, there has been some success in developing antiplatelet nutraceuticals. One such product is a water-soluble tomato-based nutraceutical given the trademarked name Fruitflow®. Fruitflow is now recognized as a functional product by the European Food Safety Authority (EFSA) with a recognized health claim that states that Fruitflow® “helps maintain normal platelet aggregation, which contributes to healthy blood flow” (94). A 3 g dose (containing 65 mg of antiplatelet components) of Fruitflow® recently demonstrated antiplatelet effects that were approximately one-third the effect of 75 mg of aspirin in a double-blinded randomized clinical trial of 47 healthy subjects (95). Nutraceuticals such as these may serve as a safe antiplatelet prophylactic treatment for those at high risk of COVID-19 who may also be at increased risk of thrombotic complications and an alternative to pharmacological compounds that may cause greater risk of bleeding"
https://www.frontiersin.org/articles/10.3389/fnut.2020.583080/full
Slam, No idea.
Maybe people take better care of themselves between March to September lol.
Bella, True, I was forgetting about confidentiality on products.
"IF didn't always know what was being launched out there and relied on your findings" Do you think he reads the BB?
Gixer (or anybody for that matter)
Does anybody have any clue as to why the income levels for H1 are so much better than the income levels for H2????
This isn't simply an observation of the latest R&A - this has happened consistently for the last 3 years and it applies to both the SSM Alliance Agreement incomes and the FF+ incomes. It is bizarre and I would really like to understand why there is such a substantial difference.
Can anybody help to explain.
Slam
Gixer.. They are DSM customers and they say what can and cannot be reported by PXS... Confidentiality!!!
As you know IF didn't always know what was being launched out there and relied on your findings. DSM HQ also doesnt always know what is being launched by their distributors customers. The others on that list are probably customers of DSM independent distributors so PXS cannot report on their launch.
Anyone buying now must have more money than sense. It is 100% certain that money will need to be raised within the next months. It says so in the finals. Remember, that money is used towards paying generous packages to the people running a company with total gross revenues of £348k from which £308k, or nearly 90%, is swallowed up by the BOD!
Ah well, the line about “and expects to make a further loss during the year ending” was in the Annuals, so more cash is required, which all suggests we won’t be seeing any cash coming from By-Health this financial year from sales of FF, or at least, if we do, then not soon enough to have a meaningful effect.
Given they havn’t started all their trials yet, I think it's hard to see By-Health getting Blue Cap before Spring 2021 at the very earliest, so, tbh, us getting any cash from DSM for FF sales to By-Health before summer 2021 seems unlikely. That may have always been the case, but plainly COVID-19 hasn't helped.
On the bright side, our share of the profits from DSM is slowly ticking up, and FF+ is paying for itself. FF+ contributed about 40k to our cashflow, though I’d imagine about half of that got swallowed up by paying Ian a full time wage rather than a part time one, so it's still as next to meaningless as makes no difference.
Bag of a fag packet calculations suggest that at current growth rates for both DSM profit share and FF+ of roughly 20% per annum, then it’d take at least three years to get to break even, with, ever decreasing, annual fund raises needed to bridge the gap.
Bottom line, as an investment, this is a punt on By-Health coming good, financially, in the next year or so. With that in mind, it’s a stick it in the bottom drawer and check it occassionally now and then kind of punt.
Mind you, I wouldn’t be surprised to see an RNS in the next 3 or 4 weeks saying Lucas has gone ( up ) through another threshold so wtfdik !
BB
You could be right but LX Yang is a relaunch of LivExtra Yang that was launched by Asim Duttaroy back in December 2017
https://www.provexis.com/?news=fruitflow-elken-mrt-malaysia-launch-livextra-yang-tri-action-blood-flow-solution
https://www.provexis.com/?news=fruitflow-elken-malaysia-heart-heart-day-25-nov-17
There were some others that looked pretty big as well
Here is what I have listed from the start of the financial year.
109/ LX Yang relaunch Sept 2020
https://www.elkenglobal.com/products/lx-yang/
108/ Thrombosol aktiv date unknown.
https://www.biofrid.de/en/thrombosol-aktiv.html
107/ Falma Core ??????? july 2020
http://www.femgj.com/cpzx/gnbj/show-103.html
106/ Flyfit july 2020
https://flyfit.com/products/flyfit-original-cranberry
105/ KardioOptimal Feb 2020
https://www.helhetshalsa.se/produkter/multi-vitamin--mineral/kardiooptimal-60-kapslar/
105/ Seribun Medusa from SERY BOX June 2020
https://www.serybox.com/board/?db=gallery_1&no=221&mari_mode=view@view
104/ vitflow oct 2019
https://www.just2bfit.nl/vitflow/
103/ Sop Subarashi triple peptide June 2020
https://ionetpromantap.wixsite.com/sop100plus
102/ Blood pressure formula May 2020
https://www.simplysupplements.co.uk/blood-pressure-formula
101/ Cardio Flow Puravida April 2020
https://www.puravida.com.br/natural/nutrientes/cardio-flow/
100/ Biogrow SmoFlow capsules April 2020
https://shopee.com.my/Biogrow-SmoFlow-Capsule-i.10699166.6818109184
Gixer I think it’s because they are larger companies than most we have been dealin with . “
With offices in 10 countries and over 1,000,000 distributors, our seal of superiority is found on hundreds of quality, innovative, and award-winning products in the categories of Health & Wellness, Beauty and Home. Our strong culture of excellence and dedication to quality has also garnered us a list of international awards and recognitions.
Our vision at Elken Global is what unites us for a common cause. We strive forward together to build individuals, families and communities to enrich their lives, and they in turn build others to help them realise their dreams.”
Out of the 11 products launched in the first half of the financial year i wonder why IF highlighted these 2.
But they have been launched ,that’s when they make money , thank you for the inevitable negative from you .